Navneet Singh (N Singh)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 55

Top Topics

Health Information

Tyrosine Kinase

Clinical Practice

Psychometric Properties

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

JCO global oncology

Exploration of targeted anti-tumor therapy

International journal of environmental health research

This page only lists publications with an associated author ORCID identifier.

Publications

Ishmael A Jaiyesimi, Natasha B Leighl, Nofisat Ismaila, Krishna C Alluri, Narjust Florez, Shirish M Gadgeel, Gregory A Masters, Erin L Schenk, Bryan J Schneider, Lecia V Sequist, Navneet Singh, Lyudmila Bazhenova, Elizabeth Blanchard, Janet Freeman-Daily, Naoki Furuya, Balazs Halmos, Ibrahim Hanna Azar, Sara Kuruvilla, Michael Mullane, Jarushka Naidoo, Joshua E Reuss, David R Spigel, Dwight H Owen, Jyoti D Patel
Therapy for Stage IV Non-Small Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, Version 2023.3. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (11) (2024)
Dwight H Owen, Nofisat Ismaila, Janet Freeman-Daily, Logan Roof, Navneet Singh, Ana I Velazquez, Natasha B Leighl
Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2024.1. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (20) (2024)
Ishmael A Jaiyesimi, Natasha B Leighl, Nofisat Ismaila, Krishna C Alluri, Narjust Florez, Shirish M Gadgeel, Gregory A Masters, Erin L Schenk, Bryan J Schneider, Lecia V Sequist, Navneet Singh, Lyudmila Bazhenova, Elizabeth Blanchard, Janet Freeman-Daily, Naoki Furuya, Balazs Halmos, Ibrahim Hanna Azar, Sara Kuruvilla, Michael Mullane, Jarushka Naidoo, Joshua E Reuss, David R Spigel, Dwight H Owen, Jyoti D Patel
Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2023.3. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (11) (2024)
Ishmael A Jaiyesimi, Natasha B Leighl, Nofisat Ismaila, Krishna C Alluri, Narjust Florez, Shirish M Gadgeel, Gregory A Masters, Erin L Schenk, Bryan J Schneider, Lecia V Sequist, Navneet Singh, Lyudmila Bazhenova, Elizabeth Blanchard, Janet Freeman-Daily, Naoki Furuya, Balazs Halmos, Ibrahim Hanna Azar, Sara Kuruvilla, Michael Mullane, Jarushka Naidoo, Joshua E Reuss, David R Spigel, Dwight H Owen, Jyoti D Patel
Therapy for Stage IV Non-Small Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, Version 2023.3. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (11) (2024)
Megan E Daly, Navneet Singh, Nofisat Ismaila, null null
Management of Stage III Non-Small Cell Lung Cancer: ASCO Guideline Rapid Recommendation Update. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (25) (2024)
Ishmael A Jaiyesimi, Natasha B Leighl, Nofisat Ismaila, Krishna C Alluri, Narjust Florez, Shirish M Gadgeel, Gregory A Masters, Erin L Schenk, Bryan J Schneider, Lecia V Sequist, Navneet Singh, Lyudmila Bazhenova, Elizabeth Blanchard, Janet Freeman-Daily, Naoki Furuya, Balazs Halmos, Ibrahim Hanna Azar, Sara Kuruvilla, Michael Mullane, Jarushka Naidoo, Joshua E Reuss, David R Spigel, Dwight H Owen, Jyoti D Patel
Therapy for Stage IV Non-Small Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, Version 2023.3. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Nithiyanandan Ravi, Parul Gupta, Amanjit Bal, Kuruswamy Thurai Prasad, Mandeep Garg, Rakesh Kapoor, Navneet Singh
Chemotherapy related changes in cfDNA levels in squamous non-small cell lung cancer: correlation with symptom scores and radiological responses. Exploration of targeted anti-tumor therapy 5 (3) (2024)
Megan E Daly, Navneet Singh, Nofisat Ismaila, null null
Management of Stage III Non-Small Cell Lung Cancer: ASCO Guideline Rapid Recommendation Update. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (25) (2024)
Ishmael A Jaiyesimi, Natasha B Leighl, Nofisat Ismaila, Krishna C Alluri, Narjust Florez, Shirish M Gadgeel, Gregory A Masters, Erin L Schenk, Bryan J Schneider, Lecia V Sequist, Navneet Singh, Lyudmila Bazhenova, Elizabeth Blanchard, Janet Freeman-Daily, Naoki Furuya, Balazs Halmos, Ibrahim Hanna Azar, Sara Kuruvilla, Michael Mullane, Jarushka Naidoo, Joshua E Reuss, David R Spigel, Dwight H Owen, Jyoti D Patel
Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2023.3. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Ishmael A Jaiyesimi, Natasha B Leighl, Nofisat Ismaila, Krishna C Alluri, Narjust Florez, Shirish M Gadgeel, Gregory A Masters, Erin L Schenk, Bryan J Schneider, Lecia V Sequist, Navneet Singh, Lyudmila Bazhenova, Elizabeth Blanchard, Janet Freeman-Daily, Naoki Furuya, Balazs Halmos, Ibrahim Hanna Azar, Sara Kuruvilla, Michael Mullane, Jarushka Naidoo, Joshua E Reuss, David R Spigel, Dwight H Owen, Jyoti D Patel
Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2023.3. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (11) (2024)
Dharna Gupta, Nidhi Gupta, Navneet Singh, Shankar Prinja
Economic Evaluation of Targeted Therapies for Anaplastic Lymphoma Kinase- and ROS1 Fusion-Positive Non-Small Cell Lung Cancer in India. JCO global oncology 10 (2024)
Arun K Mankan, Abhishek Shankar, Sewanti Limaye, Sewanti A Limaye, Prajakta Nachane, Navneet Singh, Shekhar Dawkhar, Ullas Batra, Amol Bhosekar, Sandip Ganguly, Pramod Gawli, Khokan Debnath, Vivek Padalalu, Prasanth Reddy, Shanthi Sundaramoorthy, K K Naveen, Shailesh Bondarde, Praveen Kumar, Sanish Davis, Shakti H Ramkissoon, Raju Titus Chacko, Laura Vidal, Isagani Chico, Andrew Hegedus, Sudeep Gupta, Kamal S Saini
Cancer Trials Ecosystem in India-Ready for Prime Time? JCO global oncology 10 (2024)
Ishmael A Jaiyesimi, Natasha B Leighl, Nofisat Ismaila, Krishna C Alluri, Narjust Florez, Shirish M Gadgeel, Gregory A Masters, Erin L Schenk, Bryan J Schneider, Lecia V Sequist, Navneet Singh, Lyudmila Bazhenova, Elizabeth Blanchard, Janet Freeman-Daily, Naoki Furuya, Balazs Halmos, Ibrahim Hanna Azar, Sara Kuruvilla, Michael Mullane, Jarushka Naidoo, Joshua E Reuss, David R Spigel, Dwight H Owen, Jyoti D Patel
Therapy for Stage IV Non-Small Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, Version 2023.3. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (11) (2024)
Ishmael A Jaiyesimi, Natasha B Leighl, Nofisat Ismaila, Krishna C Alluri, Narjust Florez, Shirish M Gadgeel, Gregory A Masters, Erin L Schenk, Bryan J Schneider, Lecia V Sequist, Navneet Singh, Lyudmila Bazhenova, Elizabeth Blanchard, Janet Freeman-Daily, Naoki Furuya, Balazs Halmos, Ibrahim Hanna Azar, Sara Kuruvilla, Michael Mullane, Jarushka Naidoo, Joshua E Reuss, David R Spigel, Dwight H Owen, Jyoti D Patel
Therapy for Stage IV Non-Small Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, Version 2023.3. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (11) (2024)
Ishmael A Jaiyesimi, Natasha B Leighl, Nofisat Ismaila, Krishna C Alluri, Narjust Florez, Shirish M Gadgeel, Gregory A Masters, Erin L Schenk, Bryan J Schneider, Lecia V Sequist, Navneet Singh, Lyudmila Bazhenova, Elizabeth Blanchard, Janet Freeman-Daily, Naoki Furuya, Balazs Halmos, Ibrahim Hanna Azar, Sara Kuruvilla, Michael Mullane, Jarushka Naidoo, Joshua E Reuss, David R Spigel, Dwight H Owen, Jyoti D Patel
Therapy for Stage IV Non-Small Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, Version 2023.3. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (11) (2024)
Ishmael A Jaiyesimi, Natasha B Leighl, Nofisat Ismaila, Krishna C Alluri, Narjust Florez, Shirish M Gadgeel, Gregory A Masters, Erin L Schenk, Bryan J Schneider, Lecia V Sequist, Navneet Singh, Lyudmila Bazhenova, Elizabeth Blanchard, Janet Freeman-Daily, Naoki Furuya, Balazs Halmos, Ibrahim Hanna Azar, Sara Kuruvilla, Michael Mullane, Jarushka Naidoo, Joshua E Reuss, David R Spigel, Dwight H Owen, Jyoti D Patel
Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2023.3. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (11) (2024)
Dharna Gupta, Nidhi Gupta, Navneet Singh, Shankar Prinja
Economic Evaluation of Targeted Therapies for Anaplastic Lymphoma Kinase- and ROS1 Fusion-Positive Non-Small Cell Lung Cancer in India. JCO global oncology 10 (2024)
Ishmael A Jaiyesimi, Natasha B Leighl, Nofisat Ismaila, Krishna C Alluri, Narjust Florez, Shirish M Gadgeel, Gregory A Masters, Erin L Schenk, Bryan J Schneider, Lecia V Sequist, Navneet Singh, Lyudmila Bazhenova, Elizabeth Blanchard, Janet Freeman-Daily, Naoki Furuya, Balazs Halmos, Ibrahim Hanna Azar, Sara Kuruvilla, Michael Mullane, Jarushka Naidoo, Joshua E Reuss, David R Spigel, Dwight H Owen, Jyoti D Patel
Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2023.3. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (11) (2024)
Nithiyanandan Ravi, Parul Gupta, Amanjit Bal, Kuruswamy Thurai Prasad, Mandeep Garg, Rakesh Kapoor, Navneet Singh
Chemotherapy related changes in cfDNA levels in squamous non-small cell lung cancer: correlation with symptom scores and radiological responses. Exploration of targeted anti-tumor therapy 5 (3) (2024)
Ishmael A Jaiyesimi, Natasha B Leighl, Nofisat Ismaila, Krishna C Alluri, Narjust Florez, Shirish M Gadgeel, Gregory A Masters, Erin L Schenk, Bryan J Schneider, Lecia V Sequist, Navneet Singh, Lyudmila Bazhenova, Elizabeth Blanchard, Janet Freeman-Daily, Naoki Furuya, Balazs Halmos, Ibrahim Hanna Azar, Sara Kuruvilla, Michael Mullane, Jarushka Naidoo, Joshua E Reuss, David R Spigel, Dwight H Owen, Jyoti D Patel
Therapy for Stage IV Non-Small Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, Version 2023.3. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (11) (2024)
Arun K Mankan, Abhishek Shankar, Sewanti Limaye, Sewanti A Limaye, Prajakta Nachane, Navneet Singh, Shekhar Dawkhar, Ullas Batra, Amol Bhosekar, Sandip Ganguly, Pramod Gawli, Khokan Debnath, Vivek Padalalu, Prasanth Reddy, Shanthi Sundaramoorthy, K K Naveen, Shailesh Bondarde, Praveen Kumar, Sanish Davis, Shakti H Ramkissoon, Raju Titus Chacko, Laura Vidal, Isagani Chico, Andrew Hegedus, Sudeep Gupta, Kamal S Saini
Cancer Trials Ecosystem in India-Ready for Prime Time? JCO global oncology 10 (2024)
Ishmael A Jaiyesimi, Natasha B Leighl, Nofisat Ismaila, Krishna C Alluri, Narjust Florez, Shirish M Gadgeel, Gregory A Masters, Erin L Schenk, Bryan J Schneider, Lecia V Sequist, Navneet Singh, Lyudmila Bazhenova, Elizabeth Blanchard, Janet Freeman-Daily, Naoki Furuya, Balazs Halmos, Ibrahim Hanna Azar, Sara Kuruvilla, Michael Mullane, Jarushka Naidoo, Joshua E Reuss, David R Spigel, Dwight H Owen, Jyoti D Patel
Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2023.3. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (11) (2024)
Ishmael A Jaiyesimi, Natasha B Leighl, Nofisat Ismaila, Krishna C Alluri, Narjust Florez, Shirish M Gadgeel, Gregory A Masters, Erin L Schenk, Bryan J Schneider, Lecia V Sequist, Navneet Singh, Lyudmila Bazhenova, Elizabeth Blanchard, Janet Freeman-Daily, Naoki Furuya, Balazs Halmos, Ibrahim Hanna Azar, Sara Kuruvilla, Michael Mullane, Jarushka Naidoo, Joshua E Reuss, David R Spigel, Dwight H Owen, Jyoti D Patel
Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2023.3. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (11) (2024)
Megan E Daly, Navneet Singh, Nofisat Ismaila, null null
Management of Stage III Non-Small Cell Lung Cancer: ASCO Rapid Recommendation Update. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Dwight H Owen, Nofisat Ismaila, Janet Freeman-Daily, Logan Roof, Navneet Singh, Ana I Velazquez, Natasha B Leighl
Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2024.1. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Dharna Gupta, Nidhi Gupta, Navneet Singh, Shankar Prinja
Economic Evaluation of Targeted Therapies for Anaplastic Lymphoma Kinase- and ROS1 Fusion-Positive Non-Small Cell Lung Cancer in India. JCO global oncology 10 (2024)
Shubham Shukla, Kuruswamy Thurai Prasad, Chirag Kamal Ahuja, Valliappan Muthu, Navneet Singh
Prevalence of asymptomatic brain metastases in metastatic nonsquamous nonsmall cell lung cancer: Treatment implications for resource-constrained settings. Indian journal of cancer (2023)
Ishmael A Jaiyesimi, Dwight H Owen, Nofisat Ismaila, Elizabeth Blanchard, Paul Celano, Narjust Florez, Dharamvir Jain, Navneet Singh
Therapy for Stage IV Non-Small-Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2022.3. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Dwight H Owen, Navneet Singh, Nofisat Ismaila, Gregory A Masters, Gregory J Riely, Andrew G Robinson, Bryan J Schneider, Ishmael A Jaiyesimi
Therapy for Stage IV Non-Small-Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2023.2. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Navneet Singh, Ishmael A Jaiyesimi, Nofisat Ismaila, Natasha B Leighl, Hirva Mamdani, Tanyanika Phillips, Dwight H Owen
Therapy for Stage IV Non-Small-Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2023.1. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Ishmael A Jaiyesimi, Dwight H Owen, Nofisat Ismaila, Elizabeth Blanchard, Paul Celano, Narjust Florez, Dharamvir Jain, Navneet Singh
Therapy for Stage IV Non-Small-Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2022.3. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Navneet Singh, Megan E Daly, Nofisat Ismaila, null null
Management of Stage III Non-Small-Cell Lung Cancer: ASCO Guideline Rapid Recommendation Update. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Navneet Singh, Ishmael A Jaiyesimi, Nofisat Ismaila, Natasha B Leighl, Hirva Mamdani, Tanyanika Phillips, Dwight H Owen
Therapy for Stage IV Non-Small-Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, Version 2023.1. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Ishmael A Jaiyesimi, Dwight H Owen, Nofisat Ismaila, Elizabeth Blanchard, Paul Celano, Narjust Florez, Dharamvir Jain, Navneet Singh
Therapy for Stage IV Non-Small-Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, Version 2022.3. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Dwight H Owen, Navneet Singh, Nofisat Ismaila, Elizabeth Blanchard, Paul Celano, Narjust Florez, Dharamvir Jain, Natasha B Leighl, Hirva Mamdani, Gregory A Masters, Pamela R Moffitt, Jarushka Naidoo, Tanyanika Phillips, Gregory J Riely, Andrew G Robinson, Erin L Schenk, Bryan J Schneider, Lecia V Sequist, David R Spigel, Ishmael A Jaiyesimi
Therapy for Stage IV Non-Small-Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2022.2. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 41 (5) (2022)
Dwight H Owen, Navneet Singh, Nofisat Ismaila, Elizabeth Blanchard, Paul Celano, Narjust Florez, Dharamvir Jain, Natasha B Leighl, Hirva Mamdani, Gregory A Masters, Pamela R Moffitt, Jarushka Naidoo, Tanyanika Phillips, Gregory J Riely, Andrew G Robinson, Erin L Schenk, Bryan J Schneider, Lecia V Sequist, David R Spigel, Ishmael A Jaiyesimi
Therapy for Stage IV Non-Small-Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2022.2. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Dwight H Owen, Navneet Singh, Nofisat Ismaila, Elizabeth Blanchard, Paul Celano, Narjust Florez, Dharamvir Jain, Natasha B Leighl, Hirva Mamdani, Gregory A Masters, Pamela R Moffitt, Jarushka Naidoo, Tanyanika Phillips, Gregory J Riely, Andrew G Robinson, Erin L Schenk, Bryan J Schneider, Lecia V Sequist, David R Spigel, Ishmael A Jaiyesimi
Therapy for Stage IV Non-Small-Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, Version 2022.2. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 41 (5) (2022)
Dwight H Owen, Navneet Singh, Nofisat Ismaila, Elizabeth Blanchard, Paul Celano, Narjust Florez, Dharamvir Jain, Natasha B Leighl, Hirva Mamdani, Gregory A Masters, Pamela R Moffitt, Jarushka Naidoo, Tanyanika Phillips, Gregory J Riely, Andrew G Robinson, Erin L Schenk, Bryan J Schneider, Lecia V Sequist, David R Spigel, Ishmael A Jaiyesimi
Therapy for Stage IV Non-Small-Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, Version 2022.2. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 41 (5) (2022)
Dwight H Owen, Navneet Singh, Nofisat Ismaila, Elizabeth Blanchard, Paul Celano, Narjust Florez, Dharamvir Jain, Natasha B Leighl, Hirva Mamdani, Gregory A Masters, Pamela R Moffitt, Jarushka Naidoo, Tanyanika Phillips, Gregory J Riely, Andrew G Robinson, Erin L Schenk, Bryan J Schneider, Lecia V Sequist, David R Spigel, Ishmael A Jaiyesimi
Therapy for Stage IV Non-Small-Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2022.2. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 41 (5) (2022)
Ishmael A Jaiyesimi, Sarah Temin, Navneet Singh
Therapy for Stage IV Non-Small-Cell Lung Cancer With and Without Driver Alterations: ASCO Living Guidelines Q and A. JCO oncology practice 18 (10) (2022)
Dwight H Owen, Navneet Singh, Nofisat Ismaila, Elizabeth Blanchard, Paul Celano, Narjust Florez, Dharamvir Jain, Natasha B Leighl, Hirva Mamdani, Gregory A Masters, Pamela R Moffitt, Jarushka Naidoo, Tanyanika Phillips, Gregory J Riely, Andrew G Robinson, Erin L Schenk, Bryan J Schneider, Lecia V Sequist, David R Spigel, Ishmael A Jaiyesimi
Therapy for Stage IV Non-Small-Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, Version 2022.2. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Dwight H Owen, Navneet Singh, Nofisat Ismaila, Elizabeth Blanchard, Paul Celano, Narjust Florez, Dharamvir Jain, Natasha B Leighl, Hirva Mamdani, Gregory A Masters, Pamela R Moffitt, Jarushka Naidoo, Tanyanika Phillips, Gregory J Riely, Andrew G Robinson, Erin L Schenk, Bryan J Schneider, Lecia V Sequist, David R Spigel, Ishmael A Jaiyesimi
Therapy for Stage IV Non-Small-Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2022.2. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Harleen Kaur Walia, Parul Sharma, Navneet Singh, Siddharth Sharma
Synergistic polymorphic interactions of phase II metabolizing genes and their association toward lung cancer susceptibility in North Indians. International journal of environmental health research (2022)
Navneet Singh, Sarah Temin, Sherman Baker, Elizabeth Blanchard, Julie R Brahmer, Paul Celano, Narjust Florez, Peter M Ellis, Ivy B Elkins, Rami Y Haddad, Paul J Hesketh, Dharamvir Jain, David H Johnson, Natasha B Leighl, Hirva Mamdani, Gregory A Masters, Pamela R Moffitt, Tanyanika Phillips, Gregory J Riely, Nicholas G Zaorsky, Rafael Rosell, Joan H Schiller, Bryan J Schneider, David R Spigel, Ishmael A Jaiyesimi
Therapy for Stage IV Non-Small-Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (28) (2022)
Navneet Singh, Sarah Temin, Sherman Baker, Elizabeth Blanchard, Julie R Brahmer, Paul Celano, Narjust Florez, Peter M Ellis, Ivy B Elkins, Rami Y Haddad, Paul J Hesketh, Dharamvir Jain, David H Johnson, Natasha B Leighl, Hirva Mamdani, Gregory A Masters, Pamela R Moffitt, Tanyanika Phillips, Gregory J Riely, Nicholas G Zaorsky, Rafael Rosell, Joan H Schiller, Bryan J Schneider, David R Spigel, Ishmael A Jaiyesimi
Therapy for Stage IV Non-Small-Cell Lung Cancer With Driver Alterations: ASCO Living Guideline. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (28) (2022)
Harleen Kaur Walia, Parul Sharma, Navneet Singh, Siddharth Sharma
Predictive role of polymorphic variants of phase II drug metabolising enzyme in modulating toxicity in North Indian lung cancer patients undergoing chemotherapy. Xenobiotica; the fate of foreign compounds in biological systems 52 (3) (2022)
Parul Sharma, Navneet Singh, Siddharth Sharma
ATP binding cassette transporters and cancer: revisiting their controversial role. Pharmacogenomics 22 (18) (2021)
Megan E Daly, Navneet Singh, Nofisat Ismaila, Mara B Antonoff, Douglas A Arenberg, Jeffrey D Bradley, Elizabeth David, Frank C Detterbeck, Martin Früh, Matthew A Gubens, Amy C Moore, Sukhmani K Padda, Jyoti D Patel, Tanyanika Phillips, Angel Qin, Clifford G Robinson, Charles B Simone Ii
Management of Stage III Non-Small-Cell Lung Cancer: ASCO Guideline. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (12) (2021)
Harleen Kaur Walia, Navneet Singh, Siddharth Sharma
MTHFR polymorphism as a predictive biomarker for gastrointestinal and hematological toxicity in North Indian adenocarcinoma patients. Journal of chemotherapy (Florence, Italy) (2021)
Harleen Kaur Walia, Navneet Singh, Siddharth Sharma
Genetic polymorphisms in the mEH gene in relation to tobacco smoking: role in lung cancer susceptibility and survival in north Indian patients with lung cancer undergoing platinum-based chemotherapy. Future oncology (London, England) 17 (35) (2021)
Nasser H Hanna, Andrew G Robinson, Sarah Temin, Sherman Baker, Julie R Brahmer, Peter M Ellis, Laurie E Gaspar, Rami Y Haddad, Paul J Hesketh, Dharamvir Jain, Ishmael Jaiyesimi, David H Johnson, Natasha B Leighl, Pamela R Moffitt, Tanyanika Phillips, Gregory J Riely, Rafael Rosell, Joan H Schiller, Bryan J Schneider, Navneet Singh, David R Spigel, Joan Tashbar, Gregory A Masters
Therapy for Stage IV Non-Small-Cell Lung Cancer With Driver Alterations: ASCO and OH (CCO) Joint Guideline Update. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (9) (2021)
Harleen Kaur Walia, Navneet Singh, Siddharth Sharma
Association of NQO1Pro187Ser polymorphism with clinical outcomes and survival of lung cancer patients treated with platinum chemotherapy. Personalized medicine 18 (4) (2021)
Ankan Bandyopadhyay, Siddharth Sharma, Digambar Behera, Navneet Singh
UGT1A1 Gene Polymorphisms in Patients with Small Cell Lung Cancer Treated with Irinotecan-Platinum Doublet Chemotherapy and Their Association with Gastrointestinal Toxicity and Overall Survival. The oncologist 26 (8) (2021)
H K Walia, U Verma, Navneet Singh, Siddharth Sharma
Polymorphisms in GSTM1 and GSTT1 influence the response and treatment outcome in lung cancer patients treated with platinum-based chemotherapy. British journal of biomedical science 76 (4) (2019)
Navneet Singh, Milind Baldi, Jyotdeep Kaur, Valliappan Muthu, Kuruswamy T Prasad, Digambar Behera, Amanjit Bal, Nalini Gupta, Rakesh Kapoor
Timing of folic acid/vitamin B12 supplementation and hematologic toxicity during first-line treatment of patients with nonsquamous non-small cell lung cancer using pemetrexed-based chemotherapy: The PEMVITASTART randomized trial. Cancer 125 (13) (2019)